HADC regulates the diabetic vascular endothelial dysfunction by targetting MnSOD

Biosci Rep. 2018 Sep 28;38(5):BSR20181042. doi: 10.1042/BSR20181042. Print 2018 Oct 31.

Abstract

Vascular dysfunction is a common result of diabetes in humans. However, the mechanism underlying diabetic vascular dysfunction is not fully understood. Here in the present study, we showed that the histone deacetylase 2 (HDAC2) promoted the endothelial dysfunction induced by diabetes. The expression and activity of HDAC2 were up-regulated in vascular endothelial cells (ECs) from diabetic patients and mice. The expression of HDAC2 was also increased by high glucose stress in isolated human ECs. HDAC2 knockdown repressed the proliferation rate and promoted high glucose-induced apoptosis of ECs, which was associated with the activation of apoptotic pathways (Bcl-2, Caspase 3, and Bax). By contrast, HDAC2 overexpression led to opposing results. Significantly, we observed that HDAC2 regulated the accumulation of reactive oxygen species (ROS) induced by high glucose in ECs, which accounted for the effects of HDAC2 on proliferation and apoptosis because antioxidants, N-acetyl-l-cysteine (NAC) or MnTBAP treatment blocked the effects of HDAC2 on apoptosis of ECs under high glucose condition. Mechanism study revealed that HDAC2 bound to the promoter of MnSOD and repressed the expression of MnSOD by regulating the level of acetylated H3K9 and H3K27, which led to the promotion of oxidative stress and contributed to the function of HDAC2 in ECs under high glucose condition. Altogether, our evidence demonstrated that HDAC2-MnSOD signaling was critical in oxidative stress and proliferation as well as the survival of ECs under high glucose condition.

Keywords: HDAC2; MnSOD; apoptosis; cell proliferation; diabetes; endothelial cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / pharmacology
  • Antioxidants / pharmacology
  • Apoptosis / genetics
  • Caspase 3 / genetics
  • Diabetic Angiopathies / genetics*
  • Diabetic Angiopathies / pathology
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Endothelial Cells / pathology
  • Gene Expression Regulation / drug effects
  • Gene Knockdown Techniques
  • Glucose / metabolism
  • Histone Deacetylase 2 / antagonists & inhibitors
  • Histone Deacetylase 2 / genetics*
  • Humans
  • Metalloporphyrins / pharmacology
  • Oxidative Stress / drug effects*
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Reactive Oxygen Species / metabolism
  • Superoxide Dismutase / genetics*
  • bcl-2-Associated X Protein / genetics

Substances

  • Antioxidants
  • BCL2 protein, human
  • Metalloporphyrins
  • Proto-Oncogene Proteins c-bcl-2
  • Reactive Oxygen Species
  • bcl-2-Associated X Protein
  • manganese(III)-tetrakis(4-benzoic acid)porphyrin
  • Superoxide Dismutase
  • Caspase 3
  • Histone Deacetylase 2
  • Glucose
  • Acetylcysteine